The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease
Abstract
The first clinical case of a patient with the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) was presented by Schwartz et al. in 1957 (Am J Med 1957; 23: 529–42), describing two patients with lung cancer who developed hypo‐natraemia associated with continued urinary sodium loss. They postulated that the tumours led to the inappropriate release of antidiuretic hormone (ADH), later discovered to consist of arginine‐vasopressin (AVP). This suggestion was later confirmed in several studies. The clinical description of the syndrome has changed little since the original observation, and the cardinal findings of SIADH are as follows: (i) hyponatremia with corresponding hypo‐osmolality of the serum and extracellular fluid, (ii) continued renal excretion of sodium, (iii) absence of clinical evidence of fluid volume depletion, (iv) osmolality of the urine greater than that appropriate for the concomittant osmolality of the plasma, i.e. urine less than maximal diluted, and (v) normal function of kidneys, suprarenal glands and thyroid glands. Measurement of AVP in plasma is not a part of the definition of SIADH. SIADH may be caused by a variety of malignant tumours, but may also be caused by various other conditions, such as disorders involving the central nervous system, intrathoratic disorders such as infections, positive pressure ventilation and conditions with decrease in left atrial pressure. Also, a large number of pharmaceutical agents have been shown to produce SIADH, including a number of cytotoxic drugs such as vincristine, vinblastine, cisplatin, cyclophosphamide, and melphalan. A broad spectrum of malignant tumours has been reported to cause SIADH; however, most of these observations have been in case reports including very few patients. This includes a number of primary brain tumours, haematologic malignancies, intrathoracic non‐pulmonary cancers, skin tumours, gastrointestinal cancers, gynaecological cancer, breast‐and prostatic cancer, and sarcomas. Larger series of patients have revealed that SIADH occurs in 3% of patients with head and neck cancer (47 cases out of 1696 patients), in 0.7% of patients with non‐small‐cell lung cancer (three cases out of 427 patients), and in 15% of cases of small‐cell lung cancer (214 cases out of 1473 patients). The optimal therapy for SIADH is to treat the underlying malignant disease. If this is not possible, or if the disease has become refractory, other treatment methods are available such as water restriction, demeclocycline therapy, or, in severe cases, infusion of hypertonic saline together with furosemide during careful monitoring.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The syndrome of inappropriate secretion of antidiuretic hormone
Bartter, F. C., & Schwartz, W. B. (1967) · The American Journal of Medicine · doi:10.1016/0002-9343(67)90096-4 · Cited by 1,276
Schwartz, W. B., Bennett, W., Curelop, S., & Bartter, F. C. (1957) · The American Journal of Medicine · doi:10.1016/0002-9343(57)90224-3 · Cited by 1,151
HANTMAN, D., ROSSIER, B., ZOHLMAN, R., & SCHRIER, R. (1973) · Annals of Internal Medicine · doi:10.7326/0003-4819-78-6-870 · Cited by 256
The role of vasopressin in the impaired water excretion of myxedema
Skowsky, W. R., & Kikuchi, T. A. (1978) · The American Journal of Medicine · doi:10.1016/0002-9343(78)90581-8 · Cited by 197
Antidiuretic Action of Nicotine
Burn, J. H., Truelove, L. H., & Burn, I. (1945) · BMJ · doi:10.1136/bmj.1.4394.403 · Cited by 153
Biosynthesis of Vasopressin In Vitro and Ultrastructure of a Bronchogenic Carcinoma
George, J. M., Capen, C. C., & Phillips, A. S. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106784 · Cited by 130
Demeclocycline Treatment in the Syndrome of Inappropriate Antidiuretic Hormone Secretion
CHERRILL, D. A., STOTE, R. M., BIRGE, J. R., & SINGER, I. (1975) · Annals of Internal Medicine · doi:10.7326/0003-4819-83-5-654 · Cited by 119
Moses, A. M., Numann, P., & Miller, M. (1973) · Metabolism · doi:10.1016/0026-0495(73)90029-2 · Cited by 102
Clofibrate-Induced Antidiuresis
Moses, A. M., Howanitz, J. H., van Gemert, M., & Miller, M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107213 · Cited by 93
Antitumor effects of L6, an IgG2a antibody that reacts with most human carcinomas.
Hellström, I., Beaumier, P. L., & Hellström, K. E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.18.7059 · Cited by 91
Cited by
Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints
Chang, L.-S., Barroso-Sousa, R., Tolaney, S. M., Hodi, F. S., Kaiser, U. B., & Min, L. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00006 · Cited by 532
Cisplatin: a review of toxicities and therapeutic applications
Barabas, K., Milner, R., Lurie, D., & Adin, C. (2008) · Veterinary and Comparative Oncology · doi:10.1111/j.1476-5829.2007.00142.x · Cited by 446
Langfeldt, L. A., & Cooley, M. E. (2003) · Clinical Journal of Oncology Nursing · doi:10.1188/03.cjon.425-430 · Cited by 28
Metadata
- Authors
- SØRENSEN, J. B., ANDERSEN, M. K., & HANSEN, H. H.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1995-08
- Volume
- 238
- Issue
- 2
- Pages
- 97-110
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2061328035
- Cited by
- 303
- References
- 34
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. https://app.cochat.ai/papers/10.1111/j.1365-2796.1995.tb00907.x
- The paper
- SØRENSEN, J. B., ANDERSEN, M. K., & HANSEN, H. H. (1995). Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in malignant disease. Journal of Internal Medicine. https://doi.org/10.1111/j.1365-2796.1995.tb00907.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.